What is the proper place of the Ross procedure in our modern armamentarium?

Duke E. Cameron, Luca Vricella

Research output: Contribution to journalArticle

Abstract

Despite nearly four decades of experience, the role of pulmonary valve autotransplantation (Ross procedure) in the treatment of aortic valve disease in adults and children continues to evolve and remains controversial. As the picture of late results has unfolded, alternating waves of enthusiasm and caution have characterized its use and have led to ongoing refinements in indications and operative technique. At present, it is seen as indispensable in the treatment of aortic valve disease in infants and small children (for whom no satisfactory replacement alternative exists and for whom growth is essential), attractive for adolescents and young adults who wish to avoid anticoagulants because of childbirth and lifestyle considerations a reasonable option for selected adults who desire biologic solutions with potentially better durability than conventional bioprostheses, and contra-indicated for the elderly and those with connective tissue disorders. Young patients with bicuspid aortic valve are the most common potential recipients, but also the most controversial, because of the risk of autograft dilatation. Optimal matching of prosthesis to patient is a clinical challenge for all caretakers involved in the treatment of valvular heart disease; this review provides guidelines to identify those patients who will benefit most from the Ross procedure, and those for whom it is inadvisable.

Original languageEnglish (US)
Pages (from-to)93-98
Number of pages6
JournalCurrent Cardiology Reports
Volume9
Issue number2
DOIs
StatePublished - Apr 2007

Fingerprint

Aortic Diseases
Aortic Valve
Bioprosthesis
Pulmonary Valve
Heart Valve Diseases
Autologous Transplantation
Autografts
Connective Tissue
Anticoagulants
Prostheses and Implants
Life Style
Dilatation
Young Adult
Therapeutics
Parturition
Guidelines
Growth
Bicuspid Aortic Valve

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

What is the proper place of the Ross procedure in our modern armamentarium? / Cameron, Duke E.; Vricella, Luca.

In: Current Cardiology Reports, Vol. 9, No. 2, 04.2007, p. 93-98.

Research output: Contribution to journalArticle

@article{8d226694c115485ebec35fd4174a89b4,
title = "What is the proper place of the Ross procedure in our modern armamentarium?",
abstract = "Despite nearly four decades of experience, the role of pulmonary valve autotransplantation (Ross procedure) in the treatment of aortic valve disease in adults and children continues to evolve and remains controversial. As the picture of late results has unfolded, alternating waves of enthusiasm and caution have characterized its use and have led to ongoing refinements in indications and operative technique. At present, it is seen as indispensable in the treatment of aortic valve disease in infants and small children (for whom no satisfactory replacement alternative exists and for whom growth is essential), attractive for adolescents and young adults who wish to avoid anticoagulants because of childbirth and lifestyle considerations a reasonable option for selected adults who desire biologic solutions with potentially better durability than conventional bioprostheses, and contra-indicated for the elderly and those with connective tissue disorders. Young patients with bicuspid aortic valve are the most common potential recipients, but also the most controversial, because of the risk of autograft dilatation. Optimal matching of prosthesis to patient is a clinical challenge for all caretakers involved in the treatment of valvular heart disease; this review provides guidelines to identify those patients who will benefit most from the Ross procedure, and those for whom it is inadvisable.",
author = "Cameron, {Duke E.} and Luca Vricella",
year = "2007",
month = "4",
doi = "10.1007/BF02938334",
language = "English (US)",
volume = "9",
pages = "93--98",
journal = "Current Cardiology Reports",
issn = "1523-3782",
publisher = "Current Medicine Group",
number = "2",

}

TY - JOUR

T1 - What is the proper place of the Ross procedure in our modern armamentarium?

AU - Cameron, Duke E.

AU - Vricella, Luca

PY - 2007/4

Y1 - 2007/4

N2 - Despite nearly four decades of experience, the role of pulmonary valve autotransplantation (Ross procedure) in the treatment of aortic valve disease in adults and children continues to evolve and remains controversial. As the picture of late results has unfolded, alternating waves of enthusiasm and caution have characterized its use and have led to ongoing refinements in indications and operative technique. At present, it is seen as indispensable in the treatment of aortic valve disease in infants and small children (for whom no satisfactory replacement alternative exists and for whom growth is essential), attractive for adolescents and young adults who wish to avoid anticoagulants because of childbirth and lifestyle considerations a reasonable option for selected adults who desire biologic solutions with potentially better durability than conventional bioprostheses, and contra-indicated for the elderly and those with connective tissue disorders. Young patients with bicuspid aortic valve are the most common potential recipients, but also the most controversial, because of the risk of autograft dilatation. Optimal matching of prosthesis to patient is a clinical challenge for all caretakers involved in the treatment of valvular heart disease; this review provides guidelines to identify those patients who will benefit most from the Ross procedure, and those for whom it is inadvisable.

AB - Despite nearly four decades of experience, the role of pulmonary valve autotransplantation (Ross procedure) in the treatment of aortic valve disease in adults and children continues to evolve and remains controversial. As the picture of late results has unfolded, alternating waves of enthusiasm and caution have characterized its use and have led to ongoing refinements in indications and operative technique. At present, it is seen as indispensable in the treatment of aortic valve disease in infants and small children (for whom no satisfactory replacement alternative exists and for whom growth is essential), attractive for adolescents and young adults who wish to avoid anticoagulants because of childbirth and lifestyle considerations a reasonable option for selected adults who desire biologic solutions with potentially better durability than conventional bioprostheses, and contra-indicated for the elderly and those with connective tissue disorders. Young patients with bicuspid aortic valve are the most common potential recipients, but also the most controversial, because of the risk of autograft dilatation. Optimal matching of prosthesis to patient is a clinical challenge for all caretakers involved in the treatment of valvular heart disease; this review provides guidelines to identify those patients who will benefit most from the Ross procedure, and those for whom it is inadvisable.

UR - http://www.scopus.com/inward/record.url?scp=34247601493&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247601493&partnerID=8YFLogxK

U2 - 10.1007/BF02938334

DO - 10.1007/BF02938334

M3 - Article

VL - 9

SP - 93

EP - 98

JO - Current Cardiology Reports

JF - Current Cardiology Reports

SN - 1523-3782

IS - 2

ER -